HCA Healthcare (NYSE:HCA – Get Free Report) and AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability.
Profitability
This table compares HCA Healthcare and AirSculpt Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| HCA Healthcare | 8.77% | -244.79% | 11.10% |
| AirSculpt Technologies | -7.79% | -5.83% | -2.88% |
Analyst Recommendations
This is a breakdown of current recommendations for HCA Healthcare and AirSculpt Technologies, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| HCA Healthcare | 1 | 7 | 16 | 0 | 2.62 |
| AirSculpt Technologies | 1 | 1 | 0 | 0 | 1.50 |
HCA Healthcare currently has a consensus price target of $467.61, indicating a potential downside of 0.05%. AirSculpt Technologies has a consensus price target of $4.50, indicating a potential upside of 221.66%. Given AirSculpt Technologies’ higher probable upside, analysts clearly believe AirSculpt Technologies is more favorable than HCA Healthcare.
Risk and Volatility
HCA Healthcare has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 2.29, indicating that its stock price is 129% more volatile than the S&P 500.
Earnings and Valuation
This table compares HCA Healthcare and AirSculpt Technologies”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| HCA Healthcare | $78.01 billion | 1.30 | $6.78 billion | $29.87 | 15.66 |
| AirSculpt Technologies | $150.72 million | 0.67 | -$11.67 million | ($0.18) | -7.77 |
HCA Healthcare has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by company insiders. Comparatively, 44.6% of AirSculpt Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
HCA Healthcare beats AirSculpt Technologies on 9 of the 14 factors compared between the two stocks.
About HCA Healthcare
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
About AirSculpt Technologies
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas. The company’s body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
